恩沙替尼 T3550
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 1365267-27-1 | ¥1,990.00 | 询底价 |
1 mg | 1365267-27-1 | ¥493.00 | 询底价 |
1 mL | 1365267-27-1 | ¥1,690.00 | 询底价 |
2 mg | 1365267-27-1 | ¥737.00 | 询底价 |
100 mg | 1365267-27-1 | ¥6,630.00 | 询底价 |
50 mg | 1365267-27-1 | ¥4,790.00 | 询底价 |
25 mg | 1365267-27-1 | ¥3,290.00 | 询底价 |
5 mg | 1365267-27-1 | ¥1,380.00 | 询底价 |
Product Introduction
Bioactivity
英文名: X-376
描述: X-376 (Ensartinib) 是一种有效的ALK 抑制剂,对许多具有crizotinib 抗性的ALK 突变型和中枢神经系统转移具有高活性。它能有效地抑制野生型ALK 和ALK 变体(F1174, C1156Y, L1196M, S1206R, T1151和G1202R 突变型),IC50小于4 nM。
体外活性: Ensartinib is a selective ALK inhibitor, and provids promising advantages in terms of both Clinicalal activity and safety[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 37 mg/mL (67.59 mM)
关键字: inhibit | X-376 | X 396 | X376 | ALK tyrosine kinase receptor | Cluster of differentiation 246 | X 376 | c-Met/HGFR | X396 | CD246 | Inhibitor | Anaplastic lymphoma kinase | Anaplastic lymphoma kinase (ALK)
相关产品: PF-04217903 methanesulfonate | Ensartinib hydrochloride | Rilotumumab | Telisotuzumab | Fosgonimeton acetate | 1D228 | BAY-474 | BMS 777607 | BMS-754807 | Glesatinib hydrochloride
相关库: Drug Repurposing Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Kinase Inhibitor Library | Pediatric Drug Library | Anti-Cancer Active Compound Library | Tyrosine Kinase Inhibitor Library | Target-Focused Phenotypic Screening Library
恩沙替尼 T3550信息由TargetMol中国为您提供,如您想了解更多关于恩沙替尼 T3550报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途